中东的慢性病患者中抑郁症和药物坚持之间的关系
Abdulrahman O Alomar1, Rakan H Khushaim1, Shahad K Al-Ghanem1
1College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU.
Cureus
|October 15, 2024
概括
抑郁症显著影响中东慢性疾病患者的药物坚持. 严重的抑郁症增加了不坚持的风险,突出了综合心理健康查和护理的需要.
科学领域:
- 医学科学 医学科学 医学科学
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 药物坚持对于管理慢性疾病至关重要.
- 抑郁症是一种常见的伴随性疾病,与不良的坚持有关.
- 了解中东地区的这种联系至关重要,因为不加入会产生不利的后果.
研究的目的:
- 研究中东慢性病患者中抑郁症和药物坚持之间的关系.
- 确定与药物坚持和抑郁症相关的人口和临床因素.
主要方法:
- 一项从2024年1月到4月进行的横截面研究.
- 492名中东地区患有慢性疾病的参与者的方便采样.
- 通过在线调查问卷收集的数据评估了人口统计数据,慢性疾病,药物坚持 (ARMS) 和抑郁症严重程度 (PHQ-9).
主要成果:
- 人口统计学和坚持之间发现了显著的关联:女性 (p=0.001) 和年轻人 (20-30岁) 显示出更高的不坚持.
- 非工作人员的不遵守率 (45.4%) 比退休人员 (21.5%,p=0.003) 高.
- 严重的抑郁症强烈预测了不坚持 (RR=8.41,p<0.001);类风湿性疾病和喘患者表现出更高的抑郁和更低的坚持.
结论:
- 人口因素,慢性疾病,抑郁症和药物坚持与中东的慢性病患者有着密切的联系.
- 抑郁症是降低药物服药能力的重要预测因素.
- 建议定期进行抑郁症查和治疗,以改善慢性病患者群体的坚持.
相关概念视频
01:27Depressive Disorders: Etiology
53
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
53
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:23Antidepressant Drugs: MAOIs and Other Agents
197
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
197
01:18Depression: Overview
222
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
222
01:27Depressive Disorders: MDD and Dysthymia
62
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
62
01:25Antidepressant Drugs: Overview
372
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
372